Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
Add more filters










Publication year range
1.
Nat Commun ; 11(1): 4440, 2020 09 07.
Article in English | MEDLINE | ID: mdl-32895374

ABSTRACT

Traditionally engineered genetic circuits have almost exclusively used naturally occurring transcriptional repressors. Recently, non-natural transcription factors (repressors) have been engineered and employed in synthetic biology with great success. However, transcriptional anti-repressors have largely been absent with regard to the regulation of genes in engineered genetic circuits. Here, we present a workflow for engineering systems of non-natural anti-repressors. In this study, we create 41 inducible anti-repressors. This collection of transcription factors respond to two distinct ligands, fructose (anti-FruR) or D-ribose (anti-RbsR); and were complemented by 14 additional engineered anti-repressors that respond to the ligand isopropyl ß-d-1-thiogalactopyranoside (anti-LacI). In turn, we use this collection of anti-repressors and complementary genetic architectures to confer logical control over gene expression. Here, we achieved all NOT oriented logical controls (i.e., NOT, NOR, NAND, and XNOR). The engineered transcription factors and corresponding series, parallel, and series-parallel genetic architectures represent a nascent anti-repressor based transcriptional programming structure.


Subject(s)
Bioengineering/methods , Lac Repressors/antagonists & inhibitors , Escherichia coli Proteins/metabolism , Gene Expression/physiology , Gene Regulatory Networks , Lac Repressors/chemical synthesis , Ligands , Repressor Proteins/antagonists & inhibitors , Repressor Proteins/chemical synthesis , Synthetic Biology/methods , Transcription Factors/chemical synthesis , Transcription Factors/metabolism
2.
ACS Synth Biol ; 3(6): 410-5, 2014 Jun 20.
Article in English | MEDLINE | ID: mdl-24625092

ABSTRACT

Cell-free systems are showing increasing promise for biosynthesis of both proteins and small molecules. However, in vitro transcription and translation reactions have so far primarily been used for the production of single proteins. In order to demonstrate the possibilities for coupled reactions, we designed synthetic operons that included different combinations of wild-type or evolved biotin ligases and streptavidins and demonstrated a mechanism for self-selection of operons following expression in vitro. Peptide substrates for biotin ligase were conjugated to the DNA operons and could be modified by a biotin ligase specific for either biotin or desthiobiotin and subsequently captured via a streptavidin specific for either biotin or desthiobiotin.


Subject(s)
Genes, Synthetic , Operon/genetics , Biotin/analogs & derivatives , Biotin/chemical synthesis , Biotin/genetics , Cell-Free System/chemistry , DNA/chemistry , DNA/genetics , Gene Expression Regulation , Gene Regulatory Networks , Repressor Proteins/chemical synthesis , Repressor Proteins/genetics , Streptavidin/chemical synthesis , Streptavidin/genetics , Synthetic Biology , Transcription, Genetic , Translations
3.
Bioorg Med Chem ; 19(16): 4868-75, 2011 Aug 15.
Article in English | MEDLINE | ID: mdl-21782453

ABSTRACT

Thirty N,N'-disubstituted imidazolium salts have been synthesized and evaluated as LuxR antagonists. Substitution on one of the imidazolium nitrogen atoms includes benzhydryl, fluorenyl or cyclopentyl substituent, and alkyl chains of various lengths on the second one. Most of these compounds displayed antagonist activity, with IC(50) reaching the micromolar range for the most active ones. The disubstituted imidazolium scaffold is thus shown to be a new pertinent pharmacophore in the field of AHL dependent QS inhibition.


Subject(s)
Anti-Bacterial Agents/chemistry , Anti-Bacterial Agents/chemical synthesis , Quorum Sensing/drug effects , Repressor Proteins/antagonists & inhibitors , Repressor Proteins/chemical synthesis , Trans-Activators/antagonists & inhibitors , Trans-Activators/chemical synthesis , Anti-Bacterial Agents/pharmacology , Drug Design , Humans , Imidazoles/chemistry , Imidazoles/pharmacology , Luminescent Measurements , Microbial Sensitivity Tests , Models, Molecular , Molecular Targeted Therapy , Nitrogen/chemistry , Protein Binding , Repressor Proteins/chemistry , Repressor Proteins/pharmacology , Salts/chemistry , Trans-Activators/chemistry , Trans-Activators/pharmacology
4.
Mol Cancer Res ; 8(2): 246-53, 2010 Feb.
Article in English | MEDLINE | ID: mdl-20145034

ABSTRACT

Telomerase activation is a key step in the development of human cancers. Expression of the catalytic subunit, human telomerase reverse transcriptase (hTERT), represents the limiting factor for telomerase activity. In this study, we have used artificial zinc finger protein (ZFP) transcription factors (TF) to repress the expression of hTERT in human cancer cell lines at the transcriptional level. We have constructed four-fingered ZFPs derived from the human genome which binds 12-bp recognition sequences within the promoter of the hTERT gene and fused them with a KRAB repressor domain to create a potent transcriptional repressor. Luciferase activity was decreased by >80% in all of the transcriptional repressors with luciferase reporter assay. When they were transfected into the telomerase-positive HEK293 cell line, a decrease of mRNA level and telomerase activity together with shortening of telomere length was observed. Actual growth of HEK293 cells was also inhibited by transfection of artificial ZFP-TFs. The repression was maintained for 100 days of culture. The repression of telomerase expression by artificial ZFP-TFs targeting the promoter region of the hTERT presents a new promising strategy for inhibiting the growth of human cancer cells.


Subject(s)
Cell Transformation, Neoplastic/genetics , Repressor Proteins/genetics , Telomerase/genetics , Transcription Factors/genetics , Zinc Fingers/genetics , Antineoplastic Agents/chemical synthesis , Antineoplastic Agents/metabolism , Binding Sites/genetics , Cell Line, Tumor , Gene Targeting/methods , Growth Inhibitors/chemical synthesis , Growth Inhibitors/genetics , Growth Inhibitors/metabolism , Humans , Promoter Regions, Genetic/drug effects , Promoter Regions, Genetic/genetics , RNA, Messenger/metabolism , Regulatory Elements, Transcriptional/genetics , Repressor Proteins/chemical synthesis , Repressor Proteins/metabolism , Telomerase/metabolism , Transcription Factors/chemical synthesis , Transcription Factors/metabolism , Transfection
5.
Biopolymers ; 83(5): 508-18, 2006 Dec 05.
Article in English | MEDLINE | ID: mdl-16888773

ABSTRACT

The small GstI protein (63 amino acids) of Rhizobium leguminosarum is the endogenous inhibitor of the glnII (glutamine synthetase II) gene expression. It has been suggested that GstI has a predominantly beta-structure and mediates the block of translation and stabilization of glnII mRNA through direct binding to its 5' untranslated region. Because of the unavailability of adequate amounts of purified recombinant protein, the mechanism as well as the protein tridimensional structure remain very poorly understood. To obtain the full-length protein, we have undertaken the chemical synthesis of the protein by different approaches. In a first attempt, the stepwise synthesis was unsuccessful, with strong aggregation experienced on the N-terminal side, after residue 44 from the C-terminus. In a second approach, we set up the conditions to carry out a native chemical ligation (NCL). Albeit the protein contains two Cysteine residues, located at positions 40 and 47, to minimize the size of the N-terminal segment to be synthesized, we have devised an alternative strategy of ligation on Met32, utilizing homoCys as the ligating moiety and then alkylating the resulting polypeptide with methyl iodide. New conditions to quantitatively methylate thiol groups in complex polypeptides have been conceived, obtaining the protein in very good yields and purity. A CD spectroscopy investigation has revealed that the protein does not adopt canonical secondary structures but is very rich in beta-structure (approximately 60%), in agreement with a previous study carried out on samples obtained by recombinant methods.


Subject(s)
Bacterial Proteins/chemical synthesis , Methionine/chemistry , Repressor Proteins/chemical synthesis , Amino Acid Sequence , Bacterial Proteins/chemistry , Chromatography, High Pressure Liquid , Circular Dichroism , Cysteine/chemistry , Homocysteine/metabolism , Mass Spectrometry , Protein Structure, Secondary , Repressor Proteins/chemistry
6.
Biochemistry ; 39(40): 12494-502, 2000 Oct 10.
Article in English | MEDLINE | ID: mdl-11015231

ABSTRACT

A solvent-exposed Cys11-Cys11' disulfide bond was designed to link the antiparallel strands of the beta sheet both in the Arc repressor dimer and in a single-chain variant in which the Arc subunits are connected by a 15-residue peptide tether. In both proteins, the presence of the disulfide bond increased the T(m) by approximately 40 degrees C. In the single-chain background, the disulfide bond stabilized Arc by 8.5 kcal/mol relative to the reduced form, a significantly larger degree of stabilization than caused by other engineered disulfides and most natural disulfides. This exceptional stabilization arises from a modest effective concentration of the Cys11-Cys11' disulfide in the native state (71 M) and an anomalously low effective concentration in the denatured state (40 microM). Disulfide cross-linking of the two beta strands in the single-chain Arc background accelerated refolding by a factor of 170 into the sub-microsecond time scale. However, the major energetic effect of the disulfide occurs after the transition state for Arc refolding, slowing unfolding by 200 000-fold.


Subject(s)
Bacteriophage P22/genetics , Disulfides/chemical synthesis , Mutagenesis, Insertional , Repressor Proteins/genetics , Repressor Proteins/metabolism , Viral Proteins/genetics , Viral Proteins/metabolism , Disulfides/chemistry , Disulfides/metabolism , Guanidine , Hot Temperature , Hydrogen-Ion Concentration , Models, Chemical , Models, Molecular , Mutagenesis, Insertional/methods , Oxidation-Reduction , Protein Denaturation , Protein Folding , Repressor Proteins/chemical synthesis , Repressor Proteins/chemistry , Thermodynamics , Viral Proteins/chemical synthesis , Viral Proteins/chemistry , Viral Regulatory and Accessory Proteins
7.
Biochemistry ; 37(18): 6446-55, 1998 May 05.
Article in English | MEDLINE | ID: mdl-9572862

ABSTRACT

The overall affinity of the bacteriophage lambda Cro repressor for its operator DNA site is limited by dimer dissociation at submicromolar concentrations. Since Cro dimer-operator complexes form at nanomolar concentrations of Cro subunits where free dimers are rare, these dimers must bind with compensating high affinities. Previous studies of the covalent dimer Cro V55C suggest little change in DNA binding affinity even though the dimeric species is quantitatively populated; this is an apparent contradiction to the expectation of high intrinsic dimer-DNA affinity. In contrast to the disulfide linkage at the center of the dimer interface in Cro V55C, polypeptide linkers that join the two subunits allow single-chain Cro repressors to bind operator DNA with picomolar affinities. A series of five single-chain Cro repressors have been expressed from fused tandem cro genes. Each contains a peptide linker of 8-16 hydrophilic residues that connects the C-terminus of one subunit to the N-terminus of the next. All bind to operator DNA with at least 100-fold higher affinity than Cro V55C. Proteins containing the longest and shortest linkers have been purified and characterized in detail. Both exhibit similar CD spectra to wild-type Cro and enhanced thermal stability. Sedimentation equilibrium experiments show that single-chain Cro repressors do not associate at concentrations up to 30 microM. The rate of dissociation of Cro-DNA complexes is almost unchanged by covalent linkage. Biophysical characterization of Cro variants such as these, where DNA binding is uncoupled from subunit assembly, is necessary for a quantitative understanding of the structural and energetic determinants of DNA recognition in this simple model system.


Subject(s)
Bacteriophage lambda/metabolism , DNA-Binding Proteins/metabolism , DNA/metabolism , Repressor Proteins/metabolism , Viral Proteins/metabolism , Base Sequence , DNA-Binding Proteins/chemical synthesis , Dimerization , Models, Molecular , Molecular Sequence Data , Protein Conformation , Protein Structure, Secondary , Repressor Proteins/chemical synthesis , Viral Proteins/chemical synthesis , Viral Regulatory and Accessory Proteins
8.
Biochemistry ; 36(32): 9941-9, 1997 Aug 12.
Article in English | MEDLINE | ID: mdl-9245428

ABSTRACT

Tryptophan repressor (TR) from Escherichia coli is a homodimer whose highly helical subunits intertwine in a complex fashion. A monomeric version of Trp repressor has been constructed by introducing a pair of polar amino acids at the hydrophobic dimer interface. Analytical ultracentrifugation was used to show that the replacement of leucine at position 39 with glutamic acid results in a monomer/dimer equilibrium whose dissociation constant is 1.11 x 10(-)4 M at 25 degrees C and pH 7.6. Tryptophan fluorescence, both near- and far-UV circular dichroism, and NMR spectroscopies demonstrated that, at the micromolar concentrations where the monomer predominates, secondary and tertiary structure are present. Hydrophobic dye-binding experiments showed that nonpolar surface is accessible in the monomeric form. The urea-induced equilibrium unfolding of monomeric L39E TR was monitored by circular dichroism, fluorescence, and absorbance spectroscopies. Coincident transitions show that the urea denaturation process follows a simple two-state model involving monomeric native and unfolded forms. The free energy at standard state in the absence of denaturant was estimated to be 2.37 +/- 0.15 kcal mol-1, and the sensitivity of the unfolding transition to denaturant, the m value, was 0.86 +/- 0.04 kcal mol-1 M(urea)-1 at pH 7.6 and 25 degrees C. The thermal denaturation transition occurred over a broad temperature range, suggesting either that the enthalpy change is small or that intermediates may exist. Kinetic studies showed that both the refolding and unfolding of the monomer were complete in the mixing dead time of stopped-flow CD and fluorescence spectroscopy, 5 ms. These structural, thermodynamic, and kinetic results are very similar to those previously reported for an early, monomeric intermediate in the folding of the wild-type TR dimer [Mann, C. J., & Matthews, C. R. (1993) Biochemistry 32, 5282-5290]. The construction of a stable, monomeric form of TR that strongly resembles a transient folding intermediate should provide useful insights into the nature of the early events in the folding of TR.


Subject(s)
Bacterial Proteins/chemistry , Protein Engineering , Protein Folding , Repressor Proteins/chemistry , Repressor Proteins/chemical synthesis , Tryptophan/chemistry , Bacterial Proteins/genetics , Dimerization , Drug Stability , Kinetics , Models, Molecular , Mutagenesis, Site-Directed , Protein Denaturation , Protein Structure, Secondary , Protein Structure, Tertiary , Repressor Proteins/genetics , Temperature
9.
Proc Natl Acad Sci U S A ; 91(11): 5178-82, 1994 May 24.
Article in English | MEDLINE | ID: mdl-8197204

ABSTRACT

Plasmid pLS1-encoded 45-amino acid transcriptional repressor CopG (formerly RepA) has been chemically synthesized. A one-step purification of the synthetic protein has been developed, which yields high levels of pure protein with low or no contamination of truncated products. We have compared some properties of the chemical CopG protein with those of the biologically purified CopG. The two proteins were indistinguishable in (i) their ability to generate specific protein-DNA complexes, (ii) their capacity to protect a restriction site included within the CopG DNA target, and (iii) in their in vitro capacity to specifically repress synthesis of copG mRNA.


Subject(s)
Bacterial Proteins/chemical synthesis , DNA Helicases , DNA-Binding Proteins , Proteins , Repressor Proteins/chemical synthesis , Trans-Activators , Transcription, Genetic , Amino Acid Sequence , Bacterial Proteins/metabolism , Base Sequence , DNA , Molecular Sequence Data , Repressor Proteins/metabolism
10.
Bioessays ; 14(12): 807-15, 1992 Dec.
Article in English | MEDLINE | ID: mdl-1365896

ABSTRACT

Certain sequences of double-helical DNA can be recognized and tightly bound by oligonucleotides. The effects of such triple-helical structures on DNA binding proteins have been studied. Stabilities of DNA triple-helices at or near physiological conditions are sufficient to inhibit DNA binding proteins directed to overlapping sites. Such proteins include restriction endonucleases, methylases, transcription factors, and RNA polymerases. These and other results suggest that oligonucleotide-directed triple-helix formation could provide the basis for designing artificial gene repressors. The general question of whether biological systems employ RNA molecules for recognition and regulation of double-helical DNA is discussed.


Subject(s)
DNA/ultrastructure , Nucleic Acid Conformation , Repressor Proteins/chemistry , Base Sequence , DNA/metabolism , DNA Restriction-Modification Enzymes/metabolism , DNA-Binding Proteins/chemistry , DNA-Binding Proteins/metabolism , Drug Design , Methylation , Molecular Sequence Data , Protein Binding , Repressor Proteins/chemical synthesis , Repressor Proteins/metabolism , Transcription, Genetic
11.
Antimicrob Agents Chemother ; 34(12): 2337-41, 1990 Dec.
Article in English | MEDLINE | ID: mdl-2088188

ABSTRACT

A prototype assay for the initial screening of potential antiviral agents that uses bacterial growth on selective media is described. The human immunodeficiency virus (HIV) protease recognition sequence was inserted into the tetracycline resistance (Tet) protein encoded by plasmid pBR322 of Escherichia coli. Expression of both the HIV protease and the modified Tet protein prevented growth in the presence of tetracycline. However, inhibition of the HIV protease restored tetracycline resistance. Thus, potential HIV protease inhibitors can be identified by their ability to confer tetracycline resistance to this bacterial strain. The assay is simple, rapid, and inexpensive, and this concept can be applied to the search for inhibitors of other viral proteases.


Subject(s)
Antiviral Agents/pharmacology , Base Sequence , Escherichia coli/drug effects , Escherichia coli/genetics , Gene Expression Regulation, Bacterial , HIV/drug effects , HIV/enzymology , HIV Protease/metabolism , Microbial Sensitivity Tests , Molecular Sequence Data , Pepstatins/pharmacology , Plasmids , Repressor Proteins/chemical synthesis , Repressor Proteins/chemistry , Restriction Mapping , Tetracycline/pharmacology , Tetracycline Resistance/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...